Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
farletuzumab
MeSH Supplementary Concept Data 2024
Details
Concepts
MeSH Supplementary
farletuzumab
Unique ID
C527484
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C527484
Entry Term(s)
MORAb-003
Pharm Action
Antineoplastic Agents
Registry Numbers
2O09BG0OWA
0
Previous Indexing
*ANTIBODIES, MONOCLONAL (2008-2011)
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
31
Note
a fully humanized MAb that recognizes folate receptor alpha; may be useful in treating ovarian cancer; in phase II clinical trials
Source
Curr Opin Investig Drugs 2007 Dec;8(12):1067-73
Date of Entry
2008/03/21
Revision Date
2019/10/31
Expand All
Collapse All
farletuzumab
Preferred
Concept UI
M0519608
Registry Numbers
2O09BG0OWA
Terms
farletuzumab
Preferred Term
Term UI
T770439
Date
04/28/2010
LexicalTag
NON
ThesaurusID
MORAb-003
Narrower
Concept UI
M0550791
Registry Numbers
0
Terms
MORAb-003
Preferred Term
Term UI
T716655
Date
03/21/2008
LexicalTag
LAB
ThesaurusID
NLM (2008)
page delivered in 0.008s